Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02806713 · ClinicalTrials.gov registry record · Phase 3
The Effect of Oral PhenazopyrIdine on Perioperative Voiding After Mid-urethral sliNg (EPIPhANy Study)
A Phase 3 study, sponsored by University of Massachusetts, Worcester.
- Completed
- Registry status
- Phase 3
- Development phase
- 92
- Enrollment target
NCT02806713 is a Phase 3 study that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 92 participants.
The verdict
NCT02806713, a Phase 3 study, has completed, sponsored by University of Massachusetts, Worcester.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 92 participants
- Enrollment target
Study Summary
Randomized clinical trial using phenazopyridine to decrease voiding dysfunction after a retropubic midurethral sling operation.
Interventions
- DRUG Phenazopyridine
- OTHER no Phenazopyridine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2016-02 |
| Est. Completion | 2017-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02806713
The ClinicalTrials.gov registry entry for NCT02806713 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Phenazopyridine is the first listed.
NCT02806713 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02806713 about?
NCT02806713 is a clinical study titled "The Effect of Oral PhenazopyrIdine on Perioperative Voiding After Mid-urethral sliNg (EPIPhANy Study)". Randomized clinical trial using phenazopyridine to decrease voiding dysfunction after a retropubic midurethral sling operation.
What is the current status of trial NCT02806713?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 92 participants. The study started on 2016-02. Estimated completion is 2017-08.
What interventions are being tested in trial NCT02806713?
The interventions under investigation include: Phenazopyridine (DRUG), no Phenazopyridine (OTHER).
Who is sponsoring clinical trial NCT02806713?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.